Quality of life of patients undergoing anallogeneic stem cell transplantation
Recruiting
- Conditions
- Hematologic malignancies after hematopoietic stem cell transplantation
- Registration Number
- DRKS00003878
- Lead Sponsor
- Klinik für Tumorbiologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
all patients who will be treated with an allogeneic stem cell transplantation after conventional or reduced intensity conditioning
-age = 18 years
-able to understand the intention of the study aims and to give informed consent
-able to understand and to complete the questionnaires
Exclusion Criteria
-patients younger than 18 years
-lack of informed consent
-patients who do not continue to the transplant
-no MED A data submitted to the EBMT
-patients transplanted for solid tumors
-patients participating in another quality of life study during the same period of time
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment and comparison of the quality of life (EORTC QLQ-C30, EORTC QLQ-HDC29) after allogeneic stem cell transplantation with reduced intensity or conventional conditioning
- Secondary Outcome Measures
Name Time Method Transplant related mortality; Overall survival; Event free survival; Graft versus host disease